Tresa Royo-Lopez

Zaragoza, AR 50009, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Region-Specific Expression Patterns of lncRNAs in the Central Nervous System: Cross-Species Comparison and Functional Insights.

Region-Specific Expression Patterns of lncRNAs in the Central Nervous System: Cross-Species Comparison and Functional Insights.

Journal: International journal of molecular sciences

Published: October 16, 2025

Serum lncRNAs NEAT1, PVT1 and H19 as novel biomarkers for sarcopenia diagnosis and treatment response.

Serum lncRNAs NEAT1, PVT1 and H19 as novel biomarkers for sarcopenia diagnosis and treatment response.

Journal: Non-coding RNA research

Published: May 06, 2025

LncRNA levels in the central nervous system as novel potential players and biomarkers in amyotrophic lateral sclerosis.

LncRNA levels in the central nervous system as novel potential players and biomarkers in amyotrophic lateral sclerosis.

Journal: Non-coding RNA research

Published: February 10, 2025

Differentially expressed lncRNAs in SOD1G93A mice skeletal muscle: H19, Myhas and Neat1 as potential biomarkers in amyotrophic lateral sclerosis.

Differentially expressed lncRNAs in SOD1G93A mice skeletal muscle: H19, Myhas and Neat1 as potential biomarkers in amyotrophic lateral sclerosis.

Journal: Open biology

Published: October 15, 2024

Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia.

Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia.

Journal: Journal of cachexia, sarcopenia and muscle

Published: December 15, 2023

Sex differences on constitutive long non-coding RNA expression: Modulatory effect of estradiol and testosterone in muscle cells.

Sex differences on constitutive long non-coding RNA expression: Modulatory effect of estradiol and testosterone in muscle cells.

Journal: Andrology

Published: September 19, 2023

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology.

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology.

Journal: NPJ Parkinson's disease

Published: June 01, 2022

Encapsulation of Large-Size Plasmids in PLGA Nanoparticles for Gene Editing: Comparison of Three Different Synthesis Methods.

Encapsulation of Large-Size Plasmids in PLGA Nanoparticles for Gene Editing: Comparison of Three Different Synthesis Methods.

Journal: Nanomaterials (Basel, Switzerland)

Published: August 27, 2021

Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases.

Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases.

Journal: International journal of molecular sciences

Published: November 16, 2020

What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy.

What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy.

Journal: British journal of pharmacology

Published: May 18, 2020

Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.

Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.

Journal: Glia

Published: January 24, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026